Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data BRASKEM SA files with the SEC in its annual reports.
In BRL millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2015
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Revenue
46,880
47,664
49,261
58,000
52,324
58,543
105,625
96,519
70,569
77,411
Cost of revenue
36,698
34,986
36,177
46,577
45,879
47,331
73,568
85,161
67,548
71,414
Gross profit
10,182
12,678
13,083
11,423
6,444
11,212
32,057
11,358
3,021
5,997
Research and development
170
162
167
219
248
251
297
374
383
463
Selling, general and administrative
-2,342
-2,851
3,061
3,615
-4,262
-4,077
-4,883
-5,285
Selling and marketing
5.85
7.16
General and administrative
1,095
1,286
1,434
Operating income
6,890
5,951
9,207
8,280
154
-71.9
26,044
4,272
-2,792
-1,079
Interest expense
3,163
3,571
3,747
3,008
3,883
4,913
4,903
5,066
5,589
6,853
Interest income
585
690
604
589
851
600
1,581
1,374
1,678
1,719
Pre-tax income
4,414
-140
5,265
3,605
-4,603
-9,684
17,961
47
-6,192
-17,733
Income tax
1,660
616
1,358
737
-1,963
-2,668
3,999
868
-1,302
-5,681
Income from continuing operations
2,754
-756
3,907
2,868
-2,640
-7,015
Net income to minority interests
-242
-318
50.3
40.5
-99.4
-324
-23
-485
-311
-732
Net income
3,002
-411
3,865
2,828
-2,541
-6,692
13,985
-336
-4,579
-11,320
EBITDA
4,770
3,274
6,278
EPS, basic
-0.52
4.85
3.55
-3.19
-8.41
17.57
EPS, diluted
-0.52
4.85
3.55
-3.19
-8.41
17.57
Balance sheet
FY2015
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Cash and equivalents
7,043
6,702
3,775
5,548
6,804
13,863
8,681
12,466
14,187
14,986
Short-term investments
1,190
2,303
2,358
1,688
3,627
3,493
2,295
4,956
1,786
Inventory
5,238
6,640
8,487
7,625
8,384
16,335
14,030
12,532
13,688
Total current assets
15,897
17,419
21,034
23,390
34,190
39,293
34,457
37,441
37,037
Property, plant and equipment
29,762
29,762
31,760
32,315
35,929
37,223
37,763
38,405
40,417
Lease right-of-use assets
2,606
2,902
2,779
3,953
3,820
3,719
Intangible assets
2,809
2,727
2,741
2,762
2,829
2,877
Total assets
51,822
52,732
58,808
68,129
86,084
92,564
88,049
91,741
101,575
Accounts payable
5,059
8,341
9,117
9,946
12,053
12,247
13,221
16,883
Short-term debt
2,594
1,185
737
775
1,319
1,343
1,382
2,029
2,278
Total current liabilities
22,943
18,564
22,766
16,216
28,387
25,194
24,186
24,494
28,272
Lease liabilities
90.8
2,001
2,313
2,481
3,201
2,955
3,306
Total liabilities
50,101
47,259
53,153
64,184
89,950
4,192
3,013
88,462
105,853
Total debt
23,331
23,361
24,898
29,017
41,732
34,897
35,716
42,236
53,232
Retained earnings
-218
-257
-4,530
-2,738
-14,034
Shareholders' equity
2,739
6,300
6,531
4,885
-2,202
7,866
7,322
3,992
-4,782
Minority interests
-1,018
-828
-876
-941
-1,664
-1,662
-1,214
-713
504
Total equity
945
1,721
5,473
5,655
3,945
-3,866
6,205
6,108
3,279
-4,278
Total liabilities and equity
51,822
52,732
58,808
68,129
86,084
92,564
88,049
91,741
101,575
Cash flow statement
FY2015
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Net income
2,760
-729
3,916
2,868
-2,640
-7,015
13,962
-821
-4,890
-12,052
Depreciation and amortization
-2,120
-2,678
-2,929
Cash from operations
7,092
4,458
2,462
9,250
2,265
6,293
14,786
8,952
-2,272
2,435
Capital expenditures
-3,338
-2,587
-2,273
-2,706
-2,683
-2,760
-3,421
-4,848
-4,530
-3,761
Cash from investing
-3,334
-2,552
-2,406
-2,488
-2,666
-2,722
-3,381
-4,947
-4,525
-3,485
Debt issued
5,482
4,108
8,492
4,302
20,586
13,049
16.3
6,418
Debt repaid
-6,087
-4,902
-8,779
-6,592
-17,425
-8,735
-9,414
-3,856
-2,155
-4,994
Dividends paid
-482
-1,998
-999
-1,500
-669
-2.38
-5,993
-1,350
-7
-6
Cash from financing
-97.5
-2,757
-2,988
-4,603
1,637
2,173
-16,966
225
8,873
469
Exchange rate effect
-508
587
6.48
-386
20.6
1,315
378
-444
-355
1,380
Net change in cash
3,152
-265
-2,927
1,773
1,256
7,059
-5,182
3,786
1,721
799
Free cash flow
3,754
1,871
188
6,544
-417
3,533
11,365
4,104
-6,802
-1,326
Interest paid
-1,872
1,827
2,154
1,917
2,238
2,737
2,883
2,905
3,550
4,261
Key metrics
Worked out from the statements above. Latest values use fiscal 2024. No valuation: the share price is quoted in a different currency than the statements.
Profitability
Metric
Value
How it is calculated
Gross margin
7.7%
Gross profit / revenue.
Operating margin
-1.4%
Operating income / revenue.
Pre-tax margin
-22.9%
Pre-tax income / revenue.
Net margin
-14.6%
Net income / revenue.
FCF margin
-1.7%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
3.1%
Cash from operations / revenue.
Return on assets (ROA)
-11.7%
Net income / average total assets.
Return on invested capital (ROIC)
-2.6%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
0.6%
Research and development expense / revenue.
Capex / revenue
4.9%
Capital expenditures / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
9.7%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-9.8%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
8.1%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
98.5%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-42.8%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-1.4%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow CAGR, 3y
-45.2%
Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y
1.5%
Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-219.8%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
10.7%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
3.1%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
8.3%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.31x
Current assets / current liabilities.
Quick ratio
0.59x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.59x
(Cash + short-term investments) / current liabilities.
Debt / assets
52.4%
Total debt / total assets.
Liabilities / assets
104.2%
Total liabilities / total assets.
Net debt
R$36.46B
Total debt - cash - short-term investments. Negative means more cash than debt.
Capital expenditures / cash from operations, when that is positive.
What was BRASKEM SA's revenue in fiscal 2024?
BRASKEM SA reported revenue of R$77.41B for fiscal 2024, 9.7% higher than the year before.
Was BRASKEM SA profitable in fiscal 2024?
No. It reported a net loss of R$11.32B.
How much free cash flow did BRASKEM SA generate in fiscal 2024?
Cash from operations of R$2.44B minus capital expenditures of R$3.76B left free cash flow of -R$1.33B.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.